APLN and polycystic ovary syndrome: This study highlights a significant dysregulation in vascular tone among women with PCOS, characterized by an imbalance between vasodilatory (NO and apelin) and vasoconstrictive (noradrenaline and reduced prostacyclin) factors, contributing to endothelial dysfunction and an elevated cardiovascular risk profile.